Epinephrine Intranasal Spray 2.0 mg Versus Epinephrine Injection Products: An Integrated Pharmacokinetic Analysis

MLA

Jay Lieberman, et al. “Epinephrine Intranasal Spray 2.0 Mg Versus Epinephrine Injection Products: An Integrated Pharmacokinetic Analysis.” Journal of Allergy and Clinical Immunology, vol. 151, Feb. 2023, p. AB5. EBSCOhost, https://doi.org/10.1016/j.jaci.2022.12.020.

APA

Jay Lieberman, Jay Portnoy, Michael Kaliner, Richard Lockey, Thomas Casale, Richard Lowenthal, & Sarina Tanimoto. (2023). Epinephrine Intranasal Spray 2.0 mg Versus Epinephrine Injection Products: An Integrated Pharmacokinetic Analysis. Journal of Allergy and Clinical Immunology, 151, AB5. https://doi.org/10.1016/j.jaci.2022.12.020

Chicago

Jay Lieberman, Jay Portnoy, Michael Kaliner, Richard Lockey, Thomas Casale, Richard Lowenthal, and Sarina Tanimoto. 2023. “Epinephrine Intranasal Spray 2.0 Mg Versus Epinephrine Injection Products: An Integrated Pharmacokinetic Analysis.” Journal of Allergy and Clinical Immunology 151 (February): AB5. doi:10.1016/j.jaci.2022.12.020.